[Clinical research with promolate (morphethylbutyne) as antitussive agent in some respiratory diseases].
D000284:Administration, Oral; D000996:Antitussive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001991:Bronchitis / Q000150:complications / Q000188:drug therapy; D002087:Butyrates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003371:Cough / Q000188:drug therapy*; D004311:Double-Blind Method; D004341:Drug Evaluation; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications; D009025:Morpholines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011422:Propionates; D012140:Respiratory Tract Diseases / Q000150:complications* / Q000188:drug therapy
D000996:Antitussive Agents; D002087:Butyrates; D009025:Morpholines; D011422:Propionates; C022055:promolate
Ricerche cliniche con il promolato, quale sedativo della tosse, in alcune malattie dell'apparato respiratorio.